title: TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway.
abstract: Tongue cancer resistance-associated protein 1 (TCRP1) is a novel gene located on human chromosome 11q13.4 which has been reported as a candidate related to chemotherapeutic resistance to cisplatin. Results suggest that TCRP also contribute to radioresistance in oral squamous cell carcinoma (OSCC) cells. We previously established exogenous overexpression of TCRP1 cell line Tca8113/TCRP1 and TCRP1 knockdown cell line Tca8113/PYM-siRNA and paired control cell lines, which provides a cell model system to investigate the roles and mechanisms of TCRP1-mediated radioresponse in OSCC. In this study, we first compared the radiosensitivity of up/down-regulating expression of TCRP1 cell lines and paired control cell lines by a clonogenic survival assay, Hoechst 33258 staining, cell growth assay, and comet assay. The results indicated that TCRP1 played a significant role in mediating OSCC radioresistance through decreased cells apoptosis and increased cellular proliferation and long-term survival. The further study found that TCRP1 function by up-regulating Akt activity and levels and then elevating the level of NF-κB. In summary, these results provided strong evidence for the linkage between TCRP1 and radiation sensitivity and may provide theoretical base of TCRP1 as a potential molecular mark of estimating the response for irradiation in OSCC.
authors: Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha 410078, Hunan, China.
authors: Yixue
authors: Y
authors: Gu
authors: Shasha
authors: S
authors: Fan
authors: Binjie
authors: B
authors: Liu
authors: Guopei
authors: G
authors: Zheng
authors: Yanhui
authors: Y
authors: Yu
authors: Yongmei
authors: Y
authors: Ouyang
authors: Zhimin
authors: Z
authors: He
references: Methods Mol Biol. 2008;414:13-21
references: 18175808
references: Biochem Biophys Res Commun. 2009 Sep 18;387(2):342-7
references: 19595669
references: Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):1-6
references: 12694817
references: Nat Immunol. 2002 Mar;3(3):221-7
references: 11875461
references: Biochimie. 1997 Oct;79(9-10):567-75
references: 9466694
references: Exp Mol Med. 2009 Feb 28;41(2):94-101
references: 19287190
references: CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215
references: 12139232
references: Cancer Biol Ther. 2009 Apr;8(8):730-8
references: 19252415
references: Zygote. 2004 Feb;12(1):57-64
references: 15214581
references: Exp Cell Res. 1988 Mar;175(1):184-91
references: 3345800
references: Nat Protoc. 2006;1(1):23-9
references: 17406208
references: Cell Cycle. 2003 Jul-Aug;2(4):339-45
references: 12851486
references: Med Oral Patol Oral Cir Bucal. 2008 Jun 01;13(6):E344-7
references: 18521052
references: Protein Expr Purif. 2007 May;53(1):186-94
references: 17224279
references: Am J Pathol. 1996 May;148(5):1567-76
references: 8623925
references: J Radiat Res. 2008 Mar;49(2):93-103
references: 18285658
references: Ann N Y Acad Sci. 2006 Dec;1091:151-69
references: 17341611
references: Radiother Oncol. 1996 May;39(2):155-65
references: 8735483
references: Oral Oncol. 2009 Apr-May;45(4-5):402-8
references: 19375379
references: FEBS J. 2010 Nov;277(21):4506-18
references: 21040473
references: Eur J Cell Biol. 2009 Oct;88(10):563-75
references: 19615784
references: Cancer Res. 2009 May 15;69(10):4252-9
references: 19435898
references: Prostate. 1996 Apr;28(4):251-65
references: 8602401
references: Biomed Pharmacother. 2010 Nov;64(9):600-4
references: 20947290
references: Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G865-77
references: 20299603
references: Oncogene. 2007 Feb 1;26(5):652-61
references: 16909121
references: Oral Oncol. 2009 Apr-May;45(4-5):301-8
references: 19249237